STAA Relative Valuation
STAA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, STAA is overvalued; if below, it's undervalued.
Historical Valuation
STAAR Surgical Co (STAA) is now in the Fair zone, suggesting that its current forward PE ratio of 52.32 is considered Fairly compared with the five-year average of 72.28. The fair price of STAAR Surgical Co (STAA) is between 22.10 to 70.47 according to relative valuation methord.
Relative Value
Fair Zone
22.10-70.47
Current Price：26.37
Fair
52.78
PE
1Y
3Y
5Y
Trailing
Forward
31.21
EV/EBITDA
STAAR Surgical Co. (STAA) has a current EV/EBITDA of 31.21. The 5-year average EV/EBITDA is 49.27. The thresholds are as follows: Strongly Undervalued below -62.09, Undervalued between -62.09 and -6.41, Fairly Valued between 104.95 and -6.41, Overvalued between 104.95 and 160.63, and Strongly Overvalued above 160.63. The current Forward EV/EBITDA of 31.21 falls within the Historic Trend Line -Fairly Valued range.
-2243.18
EV/EBIT
STAAR Surgical Co. (STAA) has a current EV/EBIT of -2243.18. The 5-year average EV/EBIT is 50.65. The thresholds are as follows: Strongly Undervalued below -699.83, Undervalued between -699.83 and -324.59, Fairly Valued between 425.89 and -324.59, Overvalued between 425.89 and 801.13, and Strongly Overvalued above 801.13. The current Forward EV/EBIT of -2243.18 falls within the Strongly Undervalued range.
4.18
PS
STAAR Surgical Co. (STAA) has a current PS of 4.18. The 5-year average PS is 10.21. The thresholds are as follows: Strongly Undervalued below -4.56, Undervalued between -4.56 and 2.82, Fairly Valued between 17.59 and 2.82, Overvalued between 17.59 and 24.98, and Strongly Overvalued above 24.98. The current Forward PS of 4.18 falls within the Historic Trend Line -Fairly Valued range.
119.25
P/OCF
STAAR Surgical Co. (STAA) has a current P/OCF of 119.25. The 5-year average P/OCF is 94.58. The thresholds are as follows: Strongly Undervalued below -177.20, Undervalued between -177.20 and -41.31, Fairly Valued between 230.47 and -41.31, Overvalued between 230.47 and 366.35, and Strongly Overvalued above 366.35. The current Forward P/OCF of 119.25 falls within the Historic Trend Line -Fairly Valued range.
1943.25
P/FCF
STAAR Surgical Co. (STAA) has a current P/FCF of 1943.25. The 5-year average P/FCF is 93.90. The thresholds are as follows: Strongly Undervalued below -841.72, Undervalued between -841.72 and -373.91, Fairly Valued between 561.71 and -373.91, Overvalued between 561.71 and 1029.52, and Strongly Overvalued above 1029.52. The current Forward P/FCF of 1943.25 falls within the Strongly Overvalued range.
STAAR Surgical Co (STAA) has a current Price-to-Book (P/B) ratio of 3.68. Compared to its 3-year average P/B ratio of 4.99 , the current P/B ratio is approximately -26.24% higher. Relative to its 5-year average P/B ratio of 10.66, the current P/B ratio is about -65.50% higher. STAAR Surgical Co (STAA) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -0.46%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -0.04% , the current FCF yield is about -100.00% lower.
3.71
P/B
Median3y
4.99
Median5y
10.66
-3.01
FCF Yield
Median3y
-0.46
Median5y
-0.04
Competitors Valuation Multiple
The average P/S ratio for STAA's competitors is 0.00, providing a benchmark for relative valuation. STAAR Surgical Co Corp (STAA) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 6.93%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of STAA increased by 9.51% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -11.43 to -13.64.
The secondary factor is the Revenue Growth, contributed 6.93%to the performance.
Overall, the performance of STAA in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is STAAR Surgical Co (STAA) currently overvalued or undervalued?
What is STAAR Surgical Co (STAA) fair value?
How does STAA's valuation metrics compare to the industry average?
What is the current P/B ratio for STAAR Surgical Co (STAA) as of Dec 05 2025?
What is the current FCF Yield for STAAR Surgical Co (STAA) as of Dec 05 2025?
What is the current Forward P/E ratio for STAAR Surgical Co (STAA) as of Dec 05 2025?